IN2014DN11238A - - Google Patents
Info
- Publication number
- IN2014DN11238A IN2014DN11238A IN11238DEN2014A IN2014DN11238A IN 2014DN11238 A IN2014DN11238 A IN 2014DN11238A IN 11238DEN2014 A IN11238DEN2014 A IN 11238DEN2014A IN 2014DN11238 A IN2014DN11238 A IN 2014DN11238A
- Authority
- IN
- India
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Nutrition Science (AREA)
- Endocrinology (AREA)
- Physiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Biochemistry (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1256570A FR2992861B1 (fr) | 2012-07-09 | 2012-07-09 | Utilisation de thiosulfate pour potentialiser l'effet anti-pathogene des lactobacilles |
| PCT/EP2013/064451 WO2014009349A1 (fr) | 2012-07-09 | 2013-07-09 | Utilisation de thiosulfate pour potentialiser l'effet anti-pathogene des lactobacilles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN11238A true IN2014DN11238A (fr) | 2015-10-02 |
Family
ID=46826800
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN11238DEN2014 IN2014DN11238A (fr) | 2012-07-09 | 2014-12-30 |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US20150139969A1 (fr) |
| EP (1) | EP2869825B1 (fr) |
| KR (1) | KR101972198B1 (fr) |
| CN (2) | CN112999240A (fr) |
| AU (1) | AU2013289241A1 (fr) |
| BR (1) | BR112014033013A2 (fr) |
| CA (1) | CA2877666C (fr) |
| ES (1) | ES2604880T3 (fr) |
| FR (1) | FR2992861B1 (fr) |
| IN (1) | IN2014DN11238A (fr) |
| MX (1) | MX360411B (fr) |
| PL (1) | PL2869825T3 (fr) |
| RU (1) | RU2667122C2 (fr) |
| SA (1) | SA113340702B1 (fr) |
| TW (1) | TW201414481A (fr) |
| WO (1) | WO2014009349A1 (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX383921B (es) * | 2015-06-29 | 2025-03-14 | Ferring Bv | Bacteria lactobacillus rhamnosus para el tratamiento de, por ejemplo, vaginosis bacteriana. |
| LU92820B1 (fr) * | 2015-09-08 | 2017-03-20 | Vesale Pharma International Sa | Composition comprenant au moins une bactérie probiotique et destinée à être utilisée pour le traitement de mycoses buccales |
| FR3048361B1 (fr) * | 2016-03-01 | 2020-12-18 | Biose | Compositions pour le traitement des candidoses |
| EP3548045B1 (fr) * | 2016-11-30 | 2024-06-12 | Probioswiss AG | Compositions pour utilisation dans le traitement de l'infection urogénitale |
| CN112020359A (zh) | 2018-02-09 | 2020-12-01 | 分贝治疗公司 | 含有抗铂化学保护剂的高渗药物组合物 |
| US10813947B1 (en) | 2019-05-31 | 2020-10-27 | Decibel Therapeutics, Inc. | Methods of otoprotection against platinum-based antineoplastic agents |
| CN117535205B (zh) * | 2023-12-27 | 2025-09-30 | 吉林大学 | 一株豚鼠粘液乳杆菌jl20及其应用 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US691972A (en) * | 1901-07-29 | 1902-01-28 | F W Rueckheim & Brother | Knockdown paper box. |
| FR1426226A (fr) * | 1964-11-20 | 1966-01-28 | Ct De Lyophilisation Pharma | Perfectionnements à la conservation des germes microbiens et en particulier des bacilles lactiques par lyophilisation |
| DK242083D0 (da) | 1983-05-27 | 1983-05-27 | Hansens Chr Bio Syst | Vaginalkapsler |
| ZA942302B (en) | 1993-12-03 | 1995-09-29 | Lafor Lab Ltd | Viracidal bactericidal and spermicidal vaginal suppository |
| US6093394A (en) * | 1997-04-11 | 2000-07-25 | Gynelogix, Inc. | Vaginal lactobacillus medicant |
| ES2165139T3 (es) * | 1998-04-30 | 2002-03-01 | Vesely Renata Maria Cavaliere | Composiciones farmaceuticas que contienen lactobacillus brevis y lactobacillus salivarius para el tratamiento de infecciones vaginales. |
| WO2000035465A2 (fr) | 1998-12-11 | 2000-06-22 | Urex Biotech Inc. | Administration orale de lactobacillus pour le traitement et la prevention d'infections urogenitales |
| US20020044926A1 (en) | 1999-12-10 | 2002-04-18 | Gregor Reid | Oral administration of lactobacillus for the treatment and prevention of urogenital infection |
| US6653062B1 (en) * | 2000-07-26 | 2003-11-25 | Wisconsin Alumni Research Foundation | Preservation and storage medium for biological materials |
| AU2002238861A1 (en) * | 2002-03-13 | 2003-09-22 | Matsushita Refrigeration Company | Refrigerator |
| JP4315831B2 (ja) * | 2004-02-17 | 2009-08-19 | 株式会社マンダム | 防腐殺菌剤並びに該防腐殺菌剤を配合した化粧料、医薬品及び食品 |
| EP1753445A4 (fr) * | 2004-05-06 | 2009-05-20 | Molichem Medicines Inc | Traitement de maladies et de troubles oculaires utilisant des compositions lantibiotiques |
| SE528382C2 (sv) | 2004-10-05 | 2006-10-31 | Probi Ab | Probiotiska lactobacillusstammar för förbättrad vaginal hälsa |
| JP4411181B2 (ja) * | 2004-10-22 | 2010-02-10 | キヤノン株式会社 | 画像形成装置 |
| WO2006045347A1 (fr) | 2004-10-22 | 2006-05-04 | Medinova Ag | Souche de lactobacillus helveticus utile dans le traitement ou la prevention d'infections engendrees par des pathogenes urogenitaux |
| EP3425041A1 (fr) * | 2005-01-05 | 2019-01-09 | Chr. Hansen A/S | Utilisation des composants impliqués dans la biosynthèse des acides nucléiques pour augmenter le rendement de cultures bactériennes |
| CN1888051B (zh) * | 2005-06-28 | 2010-05-05 | 北京天佑达生物工程科技有限公司 | 一株植物乳杆菌及其应用 |
| ITMI20061912A1 (it) | 2006-10-04 | 2008-04-05 | S I I T Srl | Composizioni farmaceutiche topiche vaginali |
| CN101033455A (zh) * | 2007-02-06 | 2007-09-12 | 中国农业科学院北京畜牧兽医研究所 | 一种低酸发酵加工用植物乳杆菌专用菌株及其发酵剂的制备方法 |
| MX2010003090A (es) | 2007-09-21 | 2010-04-09 | Kerry Group Services Int Ltd | Una composicion de probiotico. |
| FR2933617B1 (fr) | 2008-07-10 | 2010-09-17 | Alliospharma | Compositions visant a favoriser le developpement et la croissance d'une microflore vaginale benefique |
| DK2754354T3 (en) * | 2008-09-17 | 2016-03-21 | Bayer Cropscience Lp | A method of using a Bacillus subtilis strain to improve the animal health |
| US8329447B2 (en) * | 2008-12-12 | 2012-12-11 | Osel, Inc. | Strain of Lactobacillus crispatus |
| EP2206506A1 (fr) * | 2008-12-18 | 2010-07-14 | Bracco Imaging S.p.A | Formulations probiotiques |
| CA2762640A1 (fr) | 2009-05-22 | 2010-11-25 | Stefanie Lindemann | Medicament a administrer oralement, contenant au moins un estrogene et/ou au moins un gestagene et au moins une souche bacterienne probiotique |
| CN101919917A (zh) * | 2009-06-11 | 2010-12-22 | 张博 | 心脑肾康丸中成药 |
| AU2010270605B2 (en) * | 2009-07-08 | 2014-07-31 | Hope Medical Enterprises, Inc. Dba Hope Pharmaceuticals | Sodium thiosulfate-containing pharmaceutical compositions |
| EP2338476B1 (fr) | 2009-12-02 | 2012-06-20 | Bettina Heil | Suppositoire pour administration rectale, vaginale ou urétrale contenant un probiotique, un antibiotique et un acide gras insaturé non-estérifié |
| EP2428214A1 (fr) * | 2010-09-14 | 2012-03-14 | HSO Health Care GmbH | Compositions pour l'administration vaginale et orale de lactobacillus et utilisations correspondantes |
| CN102676429B (zh) * | 2012-05-11 | 2013-06-12 | 刘锋 | 一种耐高糖高酸的乳酸杆菌 |
| CN103074270A (zh) * | 2012-11-15 | 2013-05-01 | 上海交大昂立股份有限公司 | 一种卷曲乳杆菌及其应用 |
-
2012
- 2012-07-09 FR FR1256570A patent/FR2992861B1/fr active Active
-
2013
- 2013-07-08 TW TW102124319A patent/TW201414481A/zh unknown
- 2013-07-09 SA SA113340702A patent/SA113340702B1/ar unknown
- 2013-07-09 CN CN202110179109.6A patent/CN112999240A/zh active Pending
- 2013-07-09 EP EP13734782.9A patent/EP2869825B1/fr active Active
- 2013-07-09 US US14/413,660 patent/US20150139969A1/en not_active Abandoned
- 2013-07-09 BR BR112014033013A patent/BR112014033013A2/pt not_active IP Right Cessation
- 2013-07-09 CN CN201380039635.6A patent/CN104519892A/zh active Pending
- 2013-07-09 WO PCT/EP2013/064451 patent/WO2014009349A1/fr not_active Ceased
- 2013-07-09 AU AU2013289241A patent/AU2013289241A1/en not_active Abandoned
- 2013-07-09 ES ES13734782.9T patent/ES2604880T3/es active Active
- 2013-07-09 KR KR1020157003079A patent/KR101972198B1/ko active Active
- 2013-07-09 MX MX2015000335A patent/MX360411B/es active IP Right Grant
- 2013-07-09 PL PL13734782T patent/PL2869825T3/pl unknown
- 2013-07-09 RU RU2015103115A patent/RU2667122C2/ru active
- 2013-07-09 CA CA2877666A patent/CA2877666C/fr active Active
-
2014
- 2014-12-30 IN IN11238DEN2014 patent/IN2014DN11238A/en unknown
-
2018
- 2018-02-19 US US15/899,273 patent/US11202799B2/en active Active
-
2021
- 2021-11-11 US US17/524,388 patent/US12390489B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2015103115A (ru) | 2016-08-27 |
| MX360411B (es) | 2018-10-30 |
| PL2869825T3 (pl) | 2017-04-28 |
| US20180360874A1 (en) | 2018-12-20 |
| CN112999240A (zh) | 2021-06-22 |
| US12390489B2 (en) | 2025-08-19 |
| TW201414481A (zh) | 2014-04-16 |
| CN104519892A (zh) | 2015-04-15 |
| CA2877666A1 (fr) | 2014-01-16 |
| KR20150029737A (ko) | 2015-03-18 |
| MX2015000335A (es) | 2015-07-14 |
| FR2992861B1 (fr) | 2014-10-17 |
| US20220062330A1 (en) | 2022-03-03 |
| EP2869825A1 (fr) | 2015-05-13 |
| CA2877666C (fr) | 2020-07-14 |
| FR2992861A1 (fr) | 2014-01-10 |
| ES2604880T3 (es) | 2017-03-09 |
| RU2667122C2 (ru) | 2018-09-14 |
| US11202799B2 (en) | 2021-12-21 |
| EP2869825B1 (fr) | 2016-08-24 |
| AU2013289241A1 (en) | 2015-01-29 |
| SA113340702B1 (ar) | 2015-10-14 |
| KR101972198B1 (ko) | 2019-04-24 |
| US20150139969A1 (en) | 2015-05-21 |
| WO2014009349A1 (fr) | 2014-01-16 |
| BR112014033013A2 (pt) | 2017-06-27 |